An Extension Study to Examine the Safety and Tolerability of a New Drug in Patients With Symptoms of Overactive Bladder (OAB).
Clinical trial NCT03583372 · COMPLETED
Trial details
- NCT number
- NCT03583372
- Sponsor
- Urovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-14
- Primary completion
- 2019-06-13
- Enrollment
- 506
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.